The law firm QLT Law & Tax advised GHO Capital Partners, a global healthcare investor, on the sale of VISUfarma, a European ophthalmology company, to Lupin Limited, an Indian pharmaceutical multinational acting through its Dutch subsidiary Nanomi B.V.
The transaction forms part of a broader consolidation trend in the European pharmaceutical market and enables Lupin to strengthen its position in the ophthalmic segment and expand its commercial network internationally.
The QLT Law & Tax team — Francesco D’Amora, Federica Giannetti, and Domiziana D’Eugenio — advised GHO Capital on corporate, regulatory, and contractual aspects of the deal, with particular focus on cross-border issues and the life sciences industry.
The transaction highlights growing international investor interest in specialized European healthcare assets and confirms QLT Law & Tax’s role as a trusted advisor in complex, high-value industrial and technological M&A operations.
The full article is available onLegalcommunity.it.
